|
PAIP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.2527000000403E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72635999999837E-05 |
| Normal-vs-Stage2 |
2.411000E-01 |
| Normal-vs-Stage3 |
7.326000E-02 |
| Normal-vs-Stage4 |
7.026600E-01 |
| Stage1-vs-Stage2 |
2.832200E-01 |
| Stage1-vs-Stage3 |
4.126200E-01 |
| Stage1-vs-Stage4 |
5.808400E-02 |
| Stage2-vs-Stage3 |
7.229200E-01 |
| Stage2-vs-Stage4 |
3.062800E-01 |
| Stage3-vs-Stage4 |
1.829170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.51619999999975E-05 |
| Normal-vs-AfricanAmerican |
2.601100E-03 |
| Normal-vs-Asian |
6.860600E-01 |
| Caucasian-vs-AfricanAmerican |
7.002600E-01 |
| Caucasian-vs-Asian |
6.032800E-01 |
| AfricanAmerican-vs-Asian |
5.963400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.39280000041897E-07 |
| Normal-vs-Female |
1.108950E-01 |
| Male-vs-Female |
1.142610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.442000E-02 |
| Normal-vs-Extreme_Weight |
8.595300E-04 |
| Normal-vs-Obese |
1.123370E-03 |
| Normal-vs-Extreme_Obese |
8.543800E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.370800E-01 |
| Normal_Weight-vs-Obese |
8.792600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.861800E-01 |
| Extreme_Weight-vs-Obese |
6.386200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.030800E-01 |
| Obese-vs-Extreme_Obese |
9.820300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.380800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.615900E-02 |
| Normal-vs-Age(61-80Yrs) |
7.76859999662705E-08 |
| Normal-vs-Age(81-100Yrs) |
1.972430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.635800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.354600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.153800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.952300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.635200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.943000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.7298000000453E-06 |
| Normal-VS-Type2 PRCC |
5.570100E-02 |
| Normal-VS-KIRP CIMP |
4.060200E-02 |
| Normal-VS-Unclassified PRCC |
2.000000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.557560E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.481800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.610000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.347600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.413800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.268600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.771800E-04 |
| Normal-vs-N1 |
6.552200E-01 |
| Normal-vs-N2 |
4.671200E-01 |
| N0-vs-N1 |
1.633020E-01 |
| N0-vs-N2 |
4.516000E-01 |
| N1-vs-N2 |
9.316000E-01 |
|
|
